Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-04

FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for desvenlafaxine succinate from Alembic Pharmaceuticals Limited, enabling the generic product to be marketed under app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)